Physician profile

Subhas Gupta

Plastic and Reconstructive Surgery · Loma Linda, CA

NPI 1659309805

$178,119.79

in general payments reported to CMS, 2019-2025

36 companies · $94K in 2025

The $94K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$96,500.00
Travel and Lodging$29,303.32
Food and Beverage$5,657.61
Debt Forgiveness$3,078.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Integra Lifesciences Corporation $162,347.44 2019-2025 Integra, Integra Dermal Regeneration Template, Primatrix
Abbvie INC. $3,685.90 2023-2025
Johnson & Johnson Health Care Systems INC. $3,078.00 2024
Kci USA, INC. $3,007.27 2019-2023 Prevena, V.A.C.Ulta, V.A.C. Dermatac
Musculoskeletal Transplant Foundation INC. $1,554.24 2020-2025
Solventum Corporation $1,269.36 2024-2025 Prevena, V.A.C. Veraflo, Abthera
Mentor Worldwide LLC $445.89 2019-2025 Mentor Memorygel Resterilizable Gel Sizer
Innovation Technologies INC $418.28 2022-2024 Irrisept
Vertex Pharmaceuticals Incorporated $378.90 2024-2025
Motiva USA, LLC $327.89 2024-2025
Axogen $225.07 2019-2025
Lifenet Health $171.42 2024 Theragenesis Wound Matrix
Rti Surgical, INC $146.23 2024
Tela Bio, INC. $135.15 2022-2025 Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex)
Wright Medical Technology, INC. $134.65 2019
Show all 35 companies
CompanyGeneral paymentsYearsTop products
Sientra, INC. $121.30 2019-2020
Acelrx Pharmaceuticals, INC. $85.02 2021
Allergan, INC. $73.58 2019-2022
Checkpoint Surgical, INC $73.24 2021-2023 Checkpoint Stimulators
Aroa Biosurgery Incorporated $58.75 2022
Kls-Martin L.P. $52.62 2025
Mimedx Group, INC. $46.35 2025
Medline Industries LP $45.24 2019
Smith+Nephew, INC. $44.18 2020
Mesh Suture INC $30.78 2023
Novo Nordisk INC $24.96 2024
Heron Therapeutics, INC. $23.11 2023 Aponvie
Bioventus LLC $20.42 2022
Boston Scientific Corporation $16.90 2021
Baxter Healthcare $16.45 2021
Coopersurgical, INC. $15.59 2025 Insorb
Zimmer Biomet Holdings, INC. $15.18 2020
Stryker Corporation $14.91 2022
Medela LLC $8.64 2020
Apyx Medical Corporation $6.88 2019

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Subhas Gupta

$178,119.79

in general payments reported 2019-2025

Years
2019-2025
Top company
Integra Lifesciences Corporation
Context
The $94K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).

https://glasscript.com/doctor/165160/subhas-gupta

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.